上半年机构增持路径披露！工银瑞信多只港股通ETF获机构力捧

Group 1 - The core viewpoint of the articles highlights the significant increase in institutional investment in Hong Kong-themed ETFs, particularly in technology and innovative pharmaceutical sectors, driven by favorable market conditions and valuation advantages [1][2][3][4] - As of June 30, 2025, institutional holdings in onshore ETFs reached 1.78 trillion units, with a notable increase of 231.76 billion units since the beginning of the year [1] - The Hong Kong stock market has seen a strong rebound, with the Hang Seng Index rising by 20% and the technology sector outperforming with a 28.38% increase in the first half of 2025 [2] Group 2 - The total institutional holdings in Hong Kong-themed ETFs increased by 62.24 billion units to 291.79 billion units, marking a growth of 27.12% [3] - The ICBC Credit Suisse Hong Kong Stock Connect Technology 30 ETF and the ICBC Credit Suisse Hong Kong Stock Connect Innovative Pharmaceutical ETF have seen substantial institutional inflows, indicating strong recognition of their investment value [1][4] - The ICBC Credit Suisse Hong Kong Stock Connect Technology 30 ETF has achieved a year-to-date return of 26.42%, significantly outperforming the Hang Seng Technology Index's return of 18.68% [4][10] Group 3 - The ICBC Credit Suisse Hong Kong Stock Connect series of ETFs has strategically focused on sectors such as technology, dividends, innovative pharmaceuticals, and automobiles, with a total increase of 14.4 billion units in institutional holdings in the first half of 2025 [4] - The management fee rates of ICBC Credit Suisse ETFs are among the lowest for similar index-tracking products, enhancing their attractiveness to long-term investors [5] - The company has established a comprehensive index family covering various categories, providing investors with a "one-stop index investment toolbox" [7] Group 4 - The company has built a competitive advantage in the ETF sector through a robust research and investment management system, ensuring product liquidity and continuous strategy innovation [6][7] - The future outlook for the Hong Kong market remains positive, with expectations of continued valuation recovery and profit growth, supported by the company's precise product layout and research capabilities [7]